Results

Total Results: 1,232 records

Showing results for "subject".

141. Llewellyn-Thomas (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/llewellyn-thomas.pdf
     January 01, 2011 - Llewellyn-Thomas Slide  1: Eliciting  Patients’ Values and Preferences in Decision Making Hilary Llewellyn-­‐Thomas, PhD Emeritus Professor Dartmouth Medical School, Hanover, NH, USA R. Trafford Crump, PhD Post-­‐Doctoral Research Fellow Centre for Health  Servic…

142. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - Although there was mention of assessment reactivity in the limitations section, the subject of research … These issues, while interesting, should be the subject of other works---both for the purposes of keeping

143. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - 1 Comparative Effectiveness Review Number 51 Dietary Supplements in Adults Taking Cardiovascular Drugs Executive Summary Background The American Heart Association estimates that more than 81 million American adults (one-third of all adults) have at least one form of cardiovascular disease (CVD).1 CVD is br…

144. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
     July 01, 2017 - Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Focus of This Summary This is a summary of a systematic review that evaluated the recent evidence regarding the benefits and adve…

145. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
     December 01, 2009 - Women who are diagnosed with malignant lesions by open surgical biopsy are often subject to an additional … procedure, including all women who had open surgical biopsy as their first biopsy procedure, will be subject

146. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - Our search strategy includes relevant medical subject headings and natural language terms for LUTS/ … Management Data fields to be extracted will include author, year of publication, sponsorship, setting, subject … [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word … 133 136. 135 and ("166".mp. or 128) [mp=title, abstract, original title, name of substance word, subject … [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer

147. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - This would be contrary to the fact that observational studies, by definition, are subject to more biases

148. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - This would be contrary to the fact that observational studies, by definition, are subject to more biases

149. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - The databases searched (see Appendix A, Table A. 3) and subject-specific search strategies tailored … New devices subject to a premarket application pathway may signal a new device addressing a potentially … Is it subject to 510(k) clearance or De Novo pathway? … Are the tools subject to approval under FDA’s premarket notification 510(k) or Premarket Approval ( … Intervention diffusion is 2 years post regulatory approval or, if not subject to FDA regulation, has

150. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - The databases searched (see Appendix A, Table A. 3) and subject-specific search strategies tailored … New devices subject to a premarket application pathway may signal a new device addressing a potentially … Is it subject to 510(k) clearance or De Novo pathway? … Are the tools subject to approval under FDA’s premarket notification 510(k) or Premarket Approval ( … Intervention diffusion is 2 years post regulatory approval or, if not subject to FDA regulation, has

151. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
     June 12, 2012 - specifically on terms related to CP and nutrition/feeding-focused interventions, including keywords, subject … headings, and a combination of subject headings and/or keywords (e.g., CP, cerebral palsy, enteral … Within each KQ, we will organize results by study design, with a focus on those designs less subject … #17 #16 AND ("1980"[PDAT] : "3000"[PDAT]) [limits to 1980 to present] 222 Key: [mh] medical subject … 163 71 #14 Published Date from: 19800101-30001231; [limits 1980-present] 71 Key: MH CINAHL Subject

152. Recombinant-Factor-Viia Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
     October 01, 2010 - The research questions and the results of the report were subject to expert input, peer review, and

153. Disposition of Comments Report for Methods for Insulin Delivery and Glucose Monitoring (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
     January 01, 2010 - All studies of rt-CGM are subject to ascertainment bias because there are more hypoglycemia and hyperglycemia … if adequate randomized CT data are available, that this type of data is far superior as it is less subject … Unlike medications, a subject does not just measure glucose and realize benefits or risks. … opinion that, if adequate RCT data are available, that this type of data is far superior as it is less subject … Peer Reviewer 4 Limitation Meta-analyses are in themselves subject to bias and risk.

154. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - 1 Comparative Effectiveness Review Number 86 Treatment for Restless Legs Syndrome Executive Summary Introduction Restless legs syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and a distressing, irresistible urge to move them. RLS can result in reduced quality o…

155. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
     January 01, 2023 - Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer Comparative Effectiveness Review Number 259 Partial Breast Irradiation for Breast Cancer Executive Summary Main Points • There was no significant difference between partial breast irrad…

156. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
     April 18, 2013 - Report, results: We estimated that investigators had to screen about two patients to enroll one subject … in RCTs of antiepileptic drugs or angiotensin II antagonists, three patients to enroll one subject … in RCTs that examined beta blockers, and four patients to enroll one subject in RCTs of antidepressants … Differences in subject characteristics in randomized controlled clinical trials that examined drugs … comments The report is considerable and I credit the investigators for the time they took to research the subject

157. Kidney-Disease-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
     October 01, 2012 - authors gratefully acknowledge the following individuals for their contributions to this project: Subject … update the report and their recommendations of any relevant new studies; the project leader and six subject

158. Methods Guide for Comparative Effectiveness Reviews - Avoiding Bias in Selecting Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
     February 01, 2013 - The possible impact of conflicts is unknown at this time, but is the subject of future research, and … While some of these issues have been touched on in this paper, they are the subject of future research

159. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
     May 01, 2014 - in starting registries or using existing ones to engage in discussions with their peers and other subject … Considerations for a Federal Sponsor Web sites funded or sponsored by Federal agencies are subject to … However, research on the subject has suggested that when individuals generally perceive knowledge as … If AHRQ or another Federal agency funds or sponsors the CoP, its activities will be subject to more … • How do you currently learn about registry practices and interact with others regarding this subject

160. Covariate Selection for Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
     January 01, 2013 - Pharmacoepidemiological studies that do not restrict analyses to incident episodes of treatments are subject … For example, self-reported body mass index will often be subject to under-reporting.